Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meijuan Huang

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Medcomm|September 4, 2025
Pleural Mesothelioma: Pathogenesis, Diagnosis, Treatment, Prognosis, and SurvivalLibo Zhang, Meijuan Huang
Heliyon|September 19, 2024
Chronic myeloid leukemia during osimertinib treatment in a non-small cell lung cancer patient: A case reportLibo Zhang, Meijuan Huang
Science in China. Series C, Life Sciences|September 3, 2008
Isolation of transcription factors binding auxin response elements using a yeast one-hybrid systemMei Qi, Meijuan Huang, Fan Chen
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 16, 2024
[Afatinib Treatment for Advanced Mixed Non-small Cell Lung Cancer 
with CRISPLD2-NRG1 Fusion: A Case Report and Literature Review]Chunmei Chen, Yang Yu, Meijuan Huang
Clinical Nuclear Medicine|February 20, 2024
Epithelial Malignant Pleural Mesothelioma Mimics Lymphoma on 18 F-FDG PET/MRI : A Case ReportTian Tian, Hangyu Xie, Meijuan Huang
American Journal of Cancer Research|August 11, 2020
Innovative strategies to advance CAR T cell therapy for solid tumorsMeijuan Huang, Jinniu Deng, Lili Gao, et al.
Cancer Medicine|May 22, 2023
Immunotherapy or antiangiogenic therapy plus chemotherapy as first-line treatment of patients with PD-L1(-) advanced non-squamous non-small cell lung cancer in a Chinese cohortRuolan Xia, Yanying Li, Ling Yang, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|October 22, 2015
[Inhibition Function of Dominant-negative Mutant Gene Survivin-D53A to SPC-A1 Lung Adenocarcinoma Xenograft in Nude Mice Models]Min Yu, Xingchen Peng, You Lu, et al.
Frontiers in Oncology|August 11, 2025
Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature reviewLiqing Yang, Meijuan Huang, Yuanzhong Chen, et al.
Oncotargets and Therapy|September 9, 2020
Coexisting of <i>COX7A2L-ALK, LINC01210-ALK, ATP13A4-ALK</i> and Acquired <i>SLCO2A1-ALK</i> in a Lung Adenocarcinoma with Rearrangements Loss During the Treatment of Crizotinib and Ceritinib: A Case ReportChengzhi Cai, Yaling Long, Yanying Li, et al.
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Medcomm|September 4, 2025
Pleural Mesothelioma: Pathogenesis, Diagnosis, Treatment, Prognosis, and SurvivalLibo Zhang, Meijuan Huang
Heliyon|September 19, 2024
Chronic myeloid leukemia during osimertinib treatment in a non-small cell lung cancer patient: A case reportLibo Zhang, Meijuan Huang
Science in China. Series C, Life Sciences|September 3, 2008
Isolation of transcription factors binding auxin response elements using a yeast one-hybrid systemMei Qi, Meijuan Huang, Fan Chen
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 16, 2024
[Afatinib Treatment for Advanced Mixed Non-small Cell Lung Cancer 
with CRISPLD2-NRG1 Fusion: A Case Report and Literature Review]Chunmei Chen, Yang Yu, Meijuan Huang
Clinical Nuclear Medicine|February 20, 2024
Epithelial Malignant Pleural Mesothelioma Mimics Lymphoma on 18 F-FDG PET/MRI : A Case ReportTian Tian, Hangyu Xie, Meijuan Huang
American Journal of Cancer Research|August 11, 2020
Innovative strategies to advance CAR T cell therapy for solid tumorsMeijuan Huang, Jinniu Deng, Lili Gao, et al.
Cancer Medicine|May 22, 2023
Immunotherapy or antiangiogenic therapy plus chemotherapy as first-line treatment of patients with PD-L1(-) advanced non-squamous non-small cell lung cancer in a Chinese cohortRuolan Xia, Yanying Li, Ling Yang, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|October 22, 2015
[Inhibition Function of Dominant-negative Mutant Gene Survivin-D53A to SPC-A1 Lung Adenocarcinoma Xenograft in Nude Mice Models]Min Yu, Xingchen Peng, You Lu, et al.
Frontiers in Oncology|August 11, 2025
Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature reviewLiqing Yang, Meijuan Huang, Yuanzhong Chen, et al.
Oncotargets and Therapy|September 9, 2020
Coexisting of <i>COX7A2L-ALK, LINC01210-ALK, ATP13A4-ALK</i> and Acquired <i>SLCO2A1-ALK</i> in a Lung Adenocarcinoma with Rearrangements Loss During the Treatment of Crizotinib and Ceritinib: A Case ReportChengzhi Cai, Yaling Long, Yanying Li, et al.
Pageof 17